South Africa’s Aspen Pharmacare says that its recent strategic moves to divest its Japanese business to Sandoz and sell its local Phekolong Pharmaceuticals South African subsidiary to Laurus Labs are helping it to better position itself in the face of “challenging” market conditions.
According to Aspen, “the completion of the divesture of the Japanese business and the discontinuation of the commercial South African...




